Gagliardi Agnese, Molinaro Roberto, Fresta Massimo, Duranti Andrea, Cosco Donato
Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", 88100 Catanzaro, Italy.
IRCCS Ospedale San Raffaele srl, 20132 Milan, Italy.
Antioxidants (Basel). 2022 Mar 31;11(4):686. doi: 10.3390/antiox11040686.
-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase that preferentially catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide, which has been shown to exhibit neuroprotective and antinociceptive properties by engaging peroxisome proliferator-activated receptor-α. A few potent NAAA inhibitors have been developed, including α-acylamino-β-lactone derivatives, which are very strong and effective, but they have limited chemical and plasmatic stability, compromising their use as systemic agents. In the present study, as an example of a molecule belonging to the chemical class of -(2-oxo-3-oxetanyl)amide NAAA inhibitors, URB866 was entrapped in poly(lactic-co-glycolic acid) nanoparticles in order to increase its physical stability. The data show a monomodal pattern and a significant time- and temperature-dependent stability of the molecule-loaded nanoparticles, which also demonstrated a greater ability to effectively retain the compound. The nanoparticles improved the photostability of URB866 with respect to that of the free molecule and displayed a better antioxidant profile on various cell lines at the molecule concentration of 25 μM. Overall, these results prove that the use of polymeric nanoparticles could be a useful strategy for overcoming the instability of α-acylamino-β-lactone NAAA inhibitors, allowing the maintenance of their characteristics and activity for a longer time.
酰基乙醇胺酸酰胺酶(NAAA)是一种N端半胱氨酸水解酶,它优先催化内源性脂质介质如棕榈酰乙醇胺的水解,棕榈酰乙醇胺已被证明通过激活过氧化物酶体增殖物激活受体-α而具有神经保护和抗伤害感受特性。已经开发出了一些有效的NAAA抑制剂,包括α-酰基氨基-β-内酯衍生物,它们非常强效且有效,但化学和血浆稳定性有限,这限制了它们作为全身用药的应用。在本研究中,作为属于-(2-氧代-3-氧杂环丁烷基)酰胺NAAA抑制剂化学类别的一个分子的实例,URB866被包裹在聚乳酸-乙醇酸纳米颗粒中以提高其物理稳定性。数据显示负载分子的纳米颗粒呈现单峰模式以及显著的时间和温度依赖性稳定性,这也表明其具有更强的有效保留该化合物的能力。与游离分子相比,纳米颗粒提高了URB866的光稳定性,并且在25μM分子浓度下对各种细胞系表现出更好的抗氧化特性。总体而言,这些结果证明使用聚合物纳米颗粒可能是克服α-酰基氨基-β-内酯NAAA抑制剂不稳定性的一种有用策略,能够使其特性和活性维持更长时间。